Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 5:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 971 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control (standard practice) Clear all

Conditions: Prostate Cancer, Cardiovascular Disease
Interventions: Nutrition, Exercise, Smoking cessation, Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), ACE inhibitor; Behavioral · Drug
Lead sponsor: McMaster University; Other
Eligibility: 45 Years and older · Male only
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 4
States / cities: Augusta, Georgia • Kansas City, Kansas • Philadelphia, Pennsylvania + 1 more

Conditions: Opioid Misuse and Addiction, Pain
Interventions: Oxycodone, Zero Opioid Protocol; Drug · Behavioral
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: African American Infant Sleep Beliefs and Practices
Interventions: Tailored education, Standard Education; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 735 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Immunization, Vaccination
Interventions: STOP-HPV prompts intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 11 Years to 17 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Itasca, Illinois

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: Symptom Care at Home with NP follow up; Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 422 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Salt Lake City, Utah • Burlington, Vermont • Richmond, Virginia

Conditions: Heart Failure
Interventions: Omecamtiv Mecarbil, Placebo, Standard of Care; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 8,256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 310
States / cities: Birmingham, Alabama • Fort Payne, Alabama • Huntsville, Alabama + 249 more

Conditions: Solid Tumor, Adult, Metastasis
Interventions: Palliative and Survivorship Care Model; Behavioral
Lead sponsor: Good Samaritan Hospital Medical Center, New York; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: West Islip, New York

Conditions: Breast Neoplasm Female
Interventions: Oculus Go Virtual Reality Goggles; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Fatigue, Cancer, Sleep Disorders
Interventions: Standard Care Control Condition, Yoga Intervention (YOCAS); Procedure
Lead sponsor: Gary Morrow; Other
Eligibility: 21 Years to 120 Years
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 11
States / cities: Decatur, Illinois • Wichita, Kansas • Grand Rapids, Michigan + 8 more

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100 µg, Nemiralisib ELLIPTA 250 µg, Nemiralisib ELLIPTA 500 µg, Nemiralisib ELLIPTA 750 µg, Albuterol (Salbutamol) MDI or nebules, Standard of care therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 943 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Mobile, Alabama • Colorado Springs, Colorado • Daytona Beach, Florida + 17 more

Conditions: Stroke Hemorrhagic
Interventions: Surgical management, Medical Management; Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 24
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Palo Alto, California + 19 more

Conditions: Phantom Limb Pain (PLP)
Interventions: virtual reality therapy, matched control group; Device · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Atrial Fibrillation (AF), Atrial Flutter
Interventions: Cardiac computed tomography angiography, Standard of care management; Diagnostic Test · Other
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Infertility
Interventions: Warmed HSG; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Bone Marrow, Stem Cell Transplant
Interventions: Massage Therapy, Humor Therapy, Relaxation Therapy; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 6 Years to 18 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 3
States / cities: Columbus, Ohio • Philadelphia, Pennsylvania • Memphis, Tennessee

Conditions: Colon Polyps and Adenomas, Colon Cancer
Interventions: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system; Device
Lead sponsor: PeerMedical Ltd.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 197 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: New York, New York

Conditions: Pain, Postoperative
Interventions: Fentanyl; Drug
Lead sponsor: Bassett Healthcare; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Cooperstown, New York

Conditions: Surgical Site Infection, Sternal Infection, Cardiac Surgery
Interventions: D-PLEX, Standard of Care; Drug · Other
Lead sponsor: PolyPid Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Rochester, Minnesota • Huston, Texas

Conditions: Mitral Valve Repair Surgery
Interventions: Artificial Intelligence Video Education Arm; Other
Lead sponsor: Joanna Chikwe; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Deep Vein Thrombosis, Venous Stasis, Venous Insufficiency, Venous Leg Ulcer, Venous Reflux, Post Thrombotic Syndrome
Interventions: Stents; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 29
States / cities: Orange, California • San Francisco, California • New Haven, Connecticut + 23 more

Conditions: Anesthesia, Anesthesia Emergence Delirium, Procedural Anxiety
Interventions: Pediatric Interactive Relational Agent (PIRA); Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 4 Years to 10 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Best Practice, Discussion, Questionnaire Administration; Other · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Adolescent HPV Vaccine, Adolescent Influenza Vaccine
Interventions: 4 Pillars Toolkit; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 11 Years to 17 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Carcinoma, Head and Neck Carcinoma, Radiation-Induced Dermatitis
Interventions: Calendula Ointment, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Polyethylene Glycol Hydrogel, Silicone-based Film Forming Topical Gel, Silver Sulfadiazine, Topical Hydrocortisone; Drug · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Toward Zero Prescribed Opioids for Outpatient General Surgery

Improving the Self-Efficacy of African American Parents in Infant Supine Sleep

The STOP-HPV Trial 3: Prompts Intervention

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

VR Ultrasound Guided Breast Localization

Yoga in Treating Sleep Disturbance in Cancer Survivors

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

Immersive Healing: The Therapeutic Potential of Virtual Reality

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study

Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation

Polyp Detection With The Peerscope System™

Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care

D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery

Video-Based AI-Generated Peri-operative Instructions for Mitral Valve Surgery

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

A Single Blinded Randomized Controlled Trial Testing the Efficacy of a Pediatric Interactive Relational Agent vs. Standard Preoperative Education

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

4 Pillars Toolkit for Adolescent Vaccination

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients